 (94.29, 88.13, 66.87 and 100 % inhibition, respectively and IC 50 values recorded were 5.48, 9.25, 20.15, 60.15g/ml 
Introduction
Diabetes mellitus is a group of metabolic diseases in which a person has high blood sugar, either because the pancreas does not produce enough insulin, or because cells do not respond to the insulin that is produced. Diabetes mellitus is considered a major health concern, as its incidence is increasing at an alarming rate, and the high invalidating effects of its long-term complications affect macro-and microvasculature, heart, kidney, eye, and nerves. Increasing evidence indicates that hyperglycemia is the initiating cause of the tissue damage occurring in diabetes [2] .Therefore, one therapeutic approach for treating diabetes is to control the hyperglycemia by reducing the absorption of glucose by inhibiting α-glucosidase. Enzyme alpha-glucosidase present in the epithelial mucosa of small intestine cleaves glycosidic bonds in complex carbohydrate to release absorbable monosaccharides. Inhibition of alpha-glucosidase in the digestive tract delay carbohydrate digestion and prolong overall carbohydrate digestion time, causing a reduction in the rate of glucose absorption and consequently blunting the postprandial blood glucose and insulin levels [4, 5] . Thus alphaglucosidase inhibitors may be an attractive therapeutic modality in type 2 diabetic patients. Reduction of advance glycation end products (AGEs) and oxidative stress in different tissues might be other appropriate approaches beside reduction of hyperlycemia. AGEs are formed in vivo through a non-enzymatic glycation of glucose and other reducing sugars with proteins via so-called Maillard reaction. Hyperglycemia and free radical formation are characteristics of diabetes which accelerate the formation of advanced glycation end products (AGEs) [5] .AGEs may produce reactive oxygen species (ROS), bind to specific cell surface receptors, and form cross-links [1, 3] . AGEs accumulate in the vessel wall, where they may perturb cell structure and function. AGEs have been implicated in both the microvascular and macrovascular complications of diabetes. AGEs may modify the extracellular matrix (ECM), modify the action of hormones, cytokines, and free radicals via engagement of cell surface receptors; and impact the function of intracellular protein. Oxidative stress in cells is directly correlated with AGE formation.Many micro and macro complications of diabetes are related to oxidative stress. Low antioxidant level is associated with high AGE formation. Thus supplementation of plant based antioxidants may be useful to reduce the complications of diabetes.
Plant-based traditional medical systems continue to provide the primary health care to more than three quarters of the world's population. Indigenous herbal drugs widely used to treat diabetes and metabolic disorders. Plants continue to play an important role in the treatment of various diseases due to multiple beneficiary compositions having lesser or no side effect, and plant-based medicines can be used as an alternative approaches to treat diabetes. Traditional lifestyle, in which diet, exercise and possibly antioxidant and hypoglycemic medicines played an important role, may have masked people in pre-diabetic state in the past. As an evaluation of the benefit of the traditional medicine in relation to diabetes, we chose to study three types of activities in those plants used by the indigenous peoples of the South India for any symptoms associated with diabetes or its complications, on the premise that a particular species has a greater potential to treat diabetes if it can reduce more number of symptoms of diabetes or its complications.
Therefore the aim of our study was to evaluate the antidiabetic and antioxidant properties of 30 traditional plants of southern part of India. Our data indicated that out of 30 plants we screened, five of them have significant alfa-glucosidase inhibition properties, five of them have AGE inhibition properties and four of them have antioxidant properties.
II.
Materials and Methods 2.1. Reagents 1,1-diphenyl-2-picrylhydrazyl(DPPH), methanol, glucose, BSA (Bovine serum albumin), sodium phosphate buffer, ascorbic acid, ethanol, para-nitrophenyl-alpha-D-glucopyranoside, ascorbic acid.
Plant material
The plants were selected on the basis of their known medicinal activities in southern part of India. These plants were known to possess different type ethano medicinal properties. 30 medicinal plants were collected from Andhra Pradesh state and authenticated by Department of Botany, Kakatiya University Warangal. All plant species were collected in the month of October -November 2012.
Extraction procedure
Samples were air dried in shade before grinding to a particle size of 850 mm. Some of the thicker root samples and market produce were frozen and dried lyophilization before grinding. Extractions were performed in distilled methanol solvent using a Soxhlet apparatus. A fifty gm of each part's powder (leaf, stem or root) was extracted with 400 mL methanol by soxhlet percolation for 48 hrs. Extracts were collected and filtered twice using Whatman No.1 filter paper. The filtrates were then concentrated by rotary evaporation under reduced pressure at 40°C. Next the concentrates were poured into glass petri-dishes and put in the oven at 60° C for further drying and the resulting paste was stored in cold until further use.
Alfa-glucosidase inhibition assay.
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Intestinal alpha-glucosidase inhibition activity: 20µl of plant extracts (5mg/ml) was incubated with 50µl of crude intestinal alpha glucosidase for 5 minutes, and then 50µl of substrate 5mM para-nitrophenylalpha-D-glucopyranoside. Absorbance was measured at 405nm. Percentage enzyme inhibition was calculated. The formula is = Control-Sample/Control 100. 21 For measurement of AGE, 40µl of the plant extract were added in 100µl of glucose and 60µl of BSA and made up the volume up to 200µl with sodium phosphate buffer in an eppendroph tube. Incubated the above solution for 12hrs at a temperature of 50°C in a water bath. The fluorescence was measured by using emissions at 440nm upon excitations at 370nm. (Munch et al., 1997).
Advanced glycation end product inhibition assay.
2.6. DPPH radical scavenging activity Assay. 22 The DPPH scavenging activity was determined by an assay modified from Khatua et al., 2012. DPPH solution was prepared at the concentration of 0.195 mg/ ml in methanol. To 150 μl of DPPH solution, 20 μl of plant extract (range 20 to 1000 μg/ml) was mixed and kept in the dark at room temperature for 60 minutes. After incubation, the absorbance was recorded at 517 nm. The results were compared with the control which contained 50μl of ethanol instead of plant extracts. The positive control used for this study was ascorbic acid. The antioxidant activity was expressed as percentage (%) inhibition = {(absorbance control 517 nm -absorbance of samples 517nm)/ absorbance of the control 517nm} × 100.
Statistics
All samples were analyzed in triplicate. Data are presented as mean ± standard error mean (SEM). Differences were evaluated by one-way analysis of variance (ANOVA) test completed by a Bonferroni's multi comparison test. Differences were considered significant at p < 0.01. The concentration giving 50% inhibition (IC 50 ) was calculated by non-linear regression with the use of Graph pad Prism Version 5.0 for Windows (Graph Pad Software, San Diego, CA, USA) (www. graphpad.com) the dose-response curve was obtained by plotting the percentage inhibition versus concentration [37] .
III. Results
3.1Alfa-glucosidase enzyme inhibition assay
During screening of 23 promising Indian medicinal plants in search of potent glucosidase enzyme inhibitors, 23plant extracts were evaluated using Acarbose as standard for alfa-glucosidase enzyme inhibition assay. Among them five plant extracts exhibited significant inhibition in terms of IC 50 values up to 3.42g/ml compared to Acarbose 0.69g/ml (Table 2 ), (Fig. 1) 
Advance glycation end product inhibition assay
In search of potent advance glycation end products inhibitors, 30 plant extracts were evaluated in a non-enzymatic assay. Amongst these 5 plants extracts exhibited significant inhibition above 75% and IC 50 values are given in Table 3 ( Fig. 2) 
3.3.DPPH free radical scavenging assay
All 30 plant extracts (Table-1 ) were evaluated for antioxidant activity. The extracts are able to reduce the stable radical DPPH to the yellow-coloured diphenylpicrylhydrazine. The scavenging effect of methanol extracts and standards with the DPPH radical is given in Table 4 .Among them, four plants have shown comparable IC 50 values and it is significant to note that two of them are much more potent than ascorbic acid ( Table 4 ).The reduction capability of DPPH radical is determined by the decrease in absorbance at 517 nm induced by antioxidants Ascorbic acid is used as standard compound (Fig. 3) .
IV. Discussion
Different alfa-glucosidase inhibitors such as Oleanolic acid and its semi synthetic derivatives 7 ,phenolic compound from aqueous extract of Myrtus communis 9 Oroxylin A, a flavone from hexane extract of Oroxylum indicum plant, 10 Nojirimycin and 1-deoxynojirimycin from Rosell (Hibiscus sabdariffa) and leaves of Morus bombysis 11 reported from plant sources,Acarbose-Glycolipids ,Miglitol -Glyset -Glycerol and Derivatives, Piperidines , Voglibose -Glycerol and Derivatives 8 are well-known and marketed. Present investigation revealed extracts of Jatropha gossypifolia bark,Cocoss nucifera flowers,Oroxylum indicum bark, Euphorbia hirta whole plant,Cochlospermum gossypium bark have exhibited remarkable activity. Therefore, based on bioassay guided information, further investigation is necessary in isolation,identification and characterization of bioactive principles.
AGEs inhibitors are phenolic compounds such as catechin, epicatechin and procyanidin B2 and phenol polymers from aqueous extract of cinnamon bark effectively scavenge reactive carbonyl species. 4 A terpenoid compound, Labdadiene dial from hexane extract of Alpinia zerumbet rhizomes 5 and a flavanol compound, mesquitol from methanolic extract of Dichrostachys cinera derived from plant sources. During our studies the extracts of Jatropha gossypifolia, Hiptage madablota, Bauhinia racemosa, Alkanna tinctoria,Euphorbia hirta, Oxalis carniculata have exhibited remarkable AGEs inhibition activity.
Well known and recognized dietary antioxidants are vitamin C, vitamin E, selenium, and carotenoids. However, recent studies have demonstrated that flavonoids found in fruits and vegetables may also act as antioxidants. Present investigation on antioxidant activity by DPPH inhibition assay, the extracts of Phyllanthus maderasipatensis, Bauhinia racemosa, Alkanna tinctoria and Ventilago maderaspatna have shown significant IC 50 values.
The reports on the preliminary phytochemical screening examination of Cochlospermum gossypium (bark), Jatropha gossypifolia (root), Bauhuni aracemosa (root) on antidiabetic activity are not available till date except Euphorbia hirta(whole plant). Euphorbia hirta has been examined earlier for the phytochemical constituents and found to possess tannins,saponins, flavonoids, steroids, cardiac glycosides and alkaloids. Hencethere is a need for further investigation to isolate, identify and characterize the active compounds from those plants which showed good antidiabetic property.Amongst them Euphorbia hirta,Jatropha gossypifolia and Bauhinia racemosa with multiple biological functions are the most promising and of great interest for further investigation in development of new potent multifunctional inhibitors in management of diabetic therapy.
V. Conclusions
Since it has been shown that the antioxidants,alfaglucosidase enzyme inhibitors, advance glycation end product inhibitors play important role and contribute to management of diabetes through different pathways, and plants being a treasury of source of various biologically active molecules.Our present studies concludes that it helped in identifying the promising plants with multiple biological functions which could be the potential source of unique bioactive therapeutic molecules for the management of hyperglycemia, diabetes and the related conditions warranting further investigation. 0   20   40   60   80   100   120   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  vitamin   c  vitamin   c   Compunds   %Inhibition 
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